WallStreetZenWallStreetZen

NASDAQ: OACC
Oaktree Acquisition Corp III Life Sciences Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Oaktree Acquisition III Life Sciences earnings were $1.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest OACC earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter.

OACC earnings history

Current Revenue
$0.0
Current Earnings
$1.3M
Current Profit Margin
0%

OACC Return on Equity

Insufficient data to display

OACC undefined

Insufficient data to display

Be the first to know when OACC announces earnings.

OACC undefined

Current Company
0.68%
Current Industry
-2.5%

OACC vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OACC$1.33M$1.33MN/A$0.12
HLXB$7.60M$7.60MN/A$0.36
RENE$8.21M$8.21M+29.10%$0.40
HVII-$47.95k-$47.95kN/A-$0.01
CLBR$5.76M$5.76M+575.00%$0.27
View Top Shell Company Stocks

Oaktree Acquisition III Life Sciences Earnings Reports & History FAQ

What was OACC's earnings growth in the past year?

As of Oaktree Acquisition III Life Sciences's earnings date in Q2 2025, Oaktree Acquisition III Life Sciences's earnings has grown year over year. OACC earnings in the past year totalled $1.33 million.

If you're new to stock investing, here's how to buy Oaktree Acquisition III Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.